The role of dendritic cell subsets in 2,4,6-trinitrobenzene sulfonic acid-induced ileitis

Journal of Autoimmunity

Volumn 34, Issue 4, 2010, Pages 380-389

  Hoshino, Shoichi ^a   Inaba, Muneo ^a   Iwai, Hiroshi ^a   Ito, Tomoki ^a   Li, Ming ^a   Eric Gershwin, M ^b   Okazaki, Kazuichi ^a   Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dendritic cells; Ileitis; PIR A B; Tolerance

Indexed keywords

CD68 ANTIGEN; CYTOKINE; GLYCOPROTEIN P 15095; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; PAIRED IMMUNOGLOBULIN LIKE RECEPTOR A; PAIRED IMMUNOGLOBULIN LIKE RECEPTOR B; RECEPTOR PROTEIN; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL STIMULATION; CELL SUBPOPULATION; CONTROLLED STUDY; DENDRITIC CELL; EFFECTOR CELL; FEMALE; ILEITIS; IMMUNE RESPONSE; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; CELL MOVEMENT; CLONAL ANERGY; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ILEITIS; INFLAMMATION; MICE; T-LYMPHOCYTES; TRINITROBENZENESULFONIC ACID;

EID: 77952238152     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.10.002     Document Type: Article

References (48)

1. Tsujikawa T., Ohta N., Nakamura T., Satoh J., Uda K., Ihara T., et al. Medium-chain triglycerides modulate ileitis induced by trinitrobenzene sulfonic acid. J Gastroenterol Hepatol 1999, 14:1166-1172.
2. Goldhill J.M., Stojadinovic A., Kiang J., Smallridge R., Shea-Donohue T. Hyperthermia prevents functional, histological and biochemical abnormalities induced during ileitis. Neurogastroenterol Motil 1999, 11:69-76.
3. Moreels T.G., De Man J.G., Dick J.M., Nieuwendijk R.J., De Winter B.Y., Lefebvre R.A., et al. Effect of TNBS-induced morphological changes on pharmacological contractility of the rat ileum. Eur J Pharmacol 2001, 423:211-222.
4. Abraham M., Karni A., Dembinsky A., Miller A., Gandhi R., Anderson D., et al. In vitro induction of regulatory T cells by anti-CD3 antibody in humans. J Autoimmun 2008, 30:21-28.
5. + T cells in TLR-4 deficient mice. J Autoimmun 2008, 31:180-187.
6. Lleo A., Selmi C., Invernizzi P., Podda M., Gershwin M.E. The consequences of apoptosis in autoimmunity. J Autoimmun 2008, 31:257-262.
7. Venkatesh J., Kawabata D., Kim S., Xu X., Chinnasamy P., Paul E., et al. Selective regulation of autoreactive B cells by FcgammaRIIB. J Autoimmun 2009, 32:149-157.
8. Xiao X., Ma B., Dong B., Zhao P., Tai N., Chen L., et al. Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice. J Autoimmun 2009, 32:85-93.
9. Kubagawa H., Burrows P.D., Cooper M.D. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc Natl Acad Sci U S A 1997, 94:5261-5266.
10. Kubagawa H., Chen C.C., Ho L.H., Shimada T.S., Gartland L., Mashburn C., et al. Biochemical nature and cellular distribution of the paired immunoglobulin-like receptors, PIR-A and PIR-B. J Exp Med 1999, 189:309-318.
11. Maeda A., Kurosaki M., Kurosaki T. Paired immunoglobulin-like receptor (PIR)-A is involved in activating mast cells through its association with Fc receptor gamma chain. J Exp Med 1998, 188:991-995.
12. Blery M., Kubagawa H., Chen C.C., Vely F., Cooper M.D., Vivier E. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. Proc Natl Acad Sci U S A 1998, 95:2446-2451.
13. Maeda A., Kurosaki M., Ono M., Takai T., Kurosaki T. Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal. J Exp Med 1998, 187:1355-1360.
14. Maeda A., Scharenberg A.M., Tsukada S., Bolen J.B., Kinet J.P., Kurosaki T. Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1. Oncogene 1999, 18:2291-2297.
15. Uehara T., Blery M., Kang D.W., Chen C.C., Ho L.H., Gartland G.L., et al. Inhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-B. J Clin Invest 2001, 108:1041-1050.
16. Torii I., Oka S., Hotomi M., Benjamin W.H., Takai T., Kearney J.F., et al. PIR-B-deficient mice are susceptible to Salmonella infection. J Immunol 2008, 181:4229-4239.
17. -/- mice. Nat Immunol 2004, 5:623-629.
18. Takai T. A novel recognition system for MHC class I molecules constituted by PIR. Adv Immunol 2005, 88:161-192.
19. Kolgazi M., Jahovic N., Yuksel M., Ercan F., Alican I. Alpha-lipoic acid modulates gut inflammation induced by trinitrobenzene sulfonic acid in rats. J Gastroenterol Hepatol 2007, 22:1859-1865.
20. Resendiz-Albor A.A., Esquivel R., Lopez-Revilla R., Verdin L., Moreno-Fierros L. Striking phenotypic and functional differences in lamina propria lymphocytes from the large and small intestine of mice. Life Sci 2005, 76:2783-2803.
21. Steinman R.M., Nussenzweig M.C. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A 2002, 99:351-358.
22. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009, 9:162-174.
23. Roncarolo M.G., Gregori S., Battaglia M., Bacchetta R., Fleischhauer K., Levings M.K. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006, 212:28-50.
24. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
25. Veldman C., Nagel A., Hertl M. Type I regulatory T cells in autoimmunity and inflammatory diseases. Int Arch Allergy Immunol 2006, 140:174-183.
26. Scalapino K.J., Daikh D.I. CTLA-4: a key regulatory point in the control of autoimmune disease. Immunol Rev 2008, 223:143-155.
27. + T-cell subsets. Eur J Immunol 2009, 39:687-690.
28. Mellow A.L., Munn D.H. IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat Rev Immunol 2004, 4:762-774.
29. Sato K., Yamashita N., Yamashita N., Baba M., Matsuyama T. Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity 2003, 18:367-379.
30. Fujita S., Seino K., Sato K., Sato Y., Eizumi K., Yamashita N., et al. Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response. Blood 2006, 107:3656-3664.
31. Hadeiba H., Sato T., Habtezion A., Oderup C., Pan J., Butcher E.C. CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat Immunol 2008, 9:1253-1260.
32. Iliev I.D., Mileti E., Matteoli G., Chieppa M., Rescigno M. Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning. Mucosal Immunol 2009, 2:340-350.
33. + regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 2007, 204:1757-1764.
34. Healy L.J., Collins H.L., Thompson S.J. Systemic administration of tolerogenic dendritic cells ameliorates murine inflammatory arthritis. Open Rheumatol J 2008, 2:71-80.
35. Li X., Yang A., Huang H., Zhang X., Town J., Davis B., et al. Induction of Th2 cell allergen tolerance by IL-10-differentiated regulatory dendritic cells. Am J Respir Cell Mol Biol 2009.
36. Grohmann U., Orabona C., Fallarino F., Vacca C., Calcinaro F., Falorni A., et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 2002, 11:1097-1101.
37. Harrison L.C., Honeyman M.C., Morahan G., Wentworth J.M., Elkassaby S., Colman P.G., et al. Type 1 diabetes: lessons for other autoimmune diseases?. J Autoimmun 2008, 31:306-310.
38. Hewagama A., Richardson B. The genetics and epigenetics of autoimmune diseases. J Autoimmun 2009, 33:3-11.
39. Jordan M.A., Baxter A.G. The genetics of immunoregulatory T cells. J Autoimmun 2008, 31:237-244.
40. Kessel A., Bamberger E., Masalha M., Toubi E. The role of T regulatory cells in human sepsis. J Autoimmun 2009, 32:211-215.
41. Morahan G., Peeva V., Mehta M., Williams R. Systems genetics can provide new insights in to immune regulation and autoimmunity. J Autoimmun 2008, 31:233-236.
42. Morris G.P., Brown N.K., Kong Y.C. Naturally-existing CD4(+)CD25(+)Foxp3(+) regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen. J Autoimmun 2009, 33:68-76.
43. Terness P., Bauer T.M., Röse L., Dufter C., Watzlik A., Simon H., et al. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 2002, 196:447-457.
44. Hwu P., Du M.X., Lapointe R., Do M., Taylor M.W., Young H.A. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 2000, 164:3596-3599.
45. Bunt S.K., Sinha P., Clements V.K., Leips J., Ostrand-Rosenberg S. Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J Immunol 2006, 176:284-290.
46. + immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1-secreting cells. J Immunol 2005, 175:8200-8208.
47. + T cells. Gastroenterology 2008, 135:234-243.
48. Haile L.A., von Wasielewski R., Gamrekelashvili J., Kruger C., Bachmann O., Westendorf A.M., et al. Myeloid-derived suppressor cells in inflammatory bowel diseases: a new immunoregulatory pathway. Gastroenterology 2008, 136:871-881.